The contract manufacturing market for live biotherapeutics and microbiome products
With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator companies alone
The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”
Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion
London Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.
The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030, predicts Roots Analysis
Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community
The fragment-based drug discovery market is projected to grow at an annualized rate of ~10%, till 2030
To order this 170+ page report, which features 55+ figures and 80+ tables, please visit https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html
The global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030, predicts Roots Analysis
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.
The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predicts Roots Analysis
With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies are gradually progressing their proprietary therapy candidates with cautious optimism
The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030
Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional injectable drug delivery systems